Further analyses of MAPKAPK2 expression in glioma tissues from multiple datasets of TCGA and CGGA indicated that MAPKAPK2 levels were higher in high-grade glioma especially GBM (Figures 1D–F). Here, MAPKAPK2 is linked to central nervous system cancer.